Some of the industry’s largest pharmaceutical companies, including Pfizer Inc. and Eli Lilly and Co., have developed a blockchain-based system to track prescription drugs across the supply chain to better halt the flow of counterfeit medicines.
AstraZeneca clinched two new deals with Chinese tech giants Alibaba and Tencent as the British drugmaker steps up the company’s drive to expand business in China.
Authorities from a record 123 countries, including the U.S. FDA, have taken action against hundreds of businesses suspected of illegally selling medicines over the internet, officials said.
Three Chinese drugmakers are under investigation for crimes including using counterfeit medicines, the industry watchdog said, as China cracks down on shoddy practices in the world’s second-biggest drugs market. The China Food and Drug Administration said it was investigating Hebei Yongfeng Yaoye, a subsidiary of Hong Kong-listed CSPC Pharmaceutical Group, as well as Gansu Dadeli […]
By Arun Ramesh, Lead Analyst, Beroe Inc. Abstract 1 Serialization – Need of the HourLack of global co-operation on agreement with one common technology over the years has delayed the process of serializing the drugs. By and large, majority of the regions have come up with consensus to have a Unique level Identification Code […]